Acalabrutinib wins US FDA approval for mantle cell lymphoma treatment

Report on AstraZeneca blood cancer drug Calquence or acalabrutinib FDA approval for mantle cell lymphoma treatment in adult patients who had at least one prior therapy.

Acalabrutinib wins US FDA approval for mantle cell lymphoma treatment

Acalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment of mantle cell lymphoma in adult patients who were subjected to a minimum of one prior therapy for the rare type of blood cancer. According to the National Cancer Institute at the National Institutes of […]

Kite Car T therapy Yescarta bags FDA approval for type of lymphatic cancer

Kite Pharma has clinched the US FDA approval for its Car T therapy Yescarta (axicabtagene ciloleucel) for treating a type of lymphatic cancer in patients who have no more treatment options left and are staring at a dire prognosis.

Kite Car T therapy Yescarta bags FDA approval for type of lymphatic cancer

Yescarta FDA approval : Kite Pharma has bagged the US FDA approval for its chimeric antigen receptor T cell (CAR T) therapy Yescarta (axicabtagene ciloleucel) for a type of lymphatic cancer (Lymphoma). FDA Approves New Lymphoma Drug Yescarta The Car T therapy from the Gilead subsidiary will be available as a new treatment option in […]

AstraZeneca lung cancer drug Tagrisso gets FDA breakthrough therapy designation

AstraZeneca lung cancer drug Tagrisso (osimertinib) for the treatment of non-small cell lung cancer (NSCLC) in a first line setting has been granted the breakthrough therapy designation by the by the US Food and Drug Administration.

AstraZeneca lung cancer drug Tagrisso gets FDA breakthrough therapy designation

Pharma news updates : Tagrisso (osimertinib), the AstraZeneca lung cancer drug has bagged the breakthrough therapy designation (BTD) from the US FDA for the treatment of non-small cell lung cancer (NSCLC) in a first line setting. The BTD designation for the AstraZeneca cancer drug is specifically for treating metastatic NSCLC patients who have tested positive […]

Panel recommends Luxturna FDA approval for rare form of blindness

Luxturna FDA approval news : An FDA panel has recommended the approval of Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics for treating a rare form of genetically inherited form of blindness.

Panel recommends Luxturna FDA approval for rare form of blindness

Luxturna FDA approval news : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics is closing in towards an FDA approval for treating blindness due to an inherited retinal disease (IRD), following the recommendation from an advisory panel of the US drug regulator. An adeno-associated viral (AAV) vector gene therapy, Luxturna has been recommended to […]

Novo Nordisk bags insulin aspart injection Fiasp FDA approval for diabetes

Check out the news story on insulin aspart injection Fiasp FDA approval of the Novo Nordisk insulin product for diabetes treatment in adult patients in the US.

Novo Nordisk bags insulin aspart injection Fiasp FDA approval for diabetes

Fiasp FDA approval : Danish pharmaceutical company Novo Nordisk has secured the US FDA approval for its new fast-acting mealtime insulin aspart injection Fiasp 100 Units/mL for diabetes treatment in adults. Already approved in Canada and Europe, Fiasp is the addition of two excipients to Novo Nordisk’s insulin aspart (NovoLog) in a new formulation with […]

Abemaciclib FDA approval : Lilly breast cancer drug gets regulatory nod

Eli Lilly and Company (Lilly) has bagged the abemaciclib FDA approval to treat advanced breast cancer in patients whose breast cancer had progressed after taking therapy that changed their hormones (endocrine therapy).

Abemaciclib FDA approval : Lilly breast cancer drug gets regulatory nod

Abemaciclib FDA approval : Eli Lilly and Company (Lilly) has secured the US FDA approval for Verzenio (abemaciclib) to treat metastatic breast cancer in patients whose disease had progressed after a prior treatment. Abemaciclib FDA Approval The breast cancer drug approval is for patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 […]

Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet

Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet

Ajanta Pharma got the final USFDA approval for Entacapone tablets which is used for treating the Parkinson’s disease. Ajanta Pharma said that it has received the final approval for Entacapone tablets from US FDA in a BSE filing. Entacapone tablets are bioequivalent generic version of Comtan tablets. Ajanta Pharma company said that they will launch […]

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

Novo Nordisk diabetes drug Victoza (liraglutide) has been approved by the US FDA for treating major cardiovascular diseases associated with type 2 diabetes.

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

Danish pharma firm Novo Nordisk has secured the approval from the U.S. Food and Drug Administration (FDA) for using its diabetes drug Victoza (liraglutide) to treat heart diseases associated with type 2 diabetes. The Novo Nordisk diabetes drug Victoza can now be used in the US to decrease the risk of major adverse cardiovascular (CV) […]

Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC

Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) as a first-line option for advanced lung cancer treatment in patients who didn’t take any medicines before for the disease.

Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC

Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) as a first-line option for advanced lung cancer treatment in patients who didn’t take any medicines before for the disease. The Keytruda chemotherapy combination has been approved to treat metastatic non-squamous non small cell lung […]

1 2 3 6